ITEOS THERAPEUTICS INC's ticker is ITOS and the CUSIP is 46565G104. A total of 145 filers reported holding ITEOS THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.75 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $231,516 | -17.4% | 21,143 | -0.1% | 0.00% | 0.0% |
| Q2 2023 | $280,132 | -6.7% | 21,158 | -4.1% | 0.00% | -25.0% |
| Q1 2023 | $300,400 | -68.2% | 22,072 | -54.4% | 0.00% | -33.3% |
| Q4 2022 | $945,330 | +122.4% | 48,404 | +117.2% | 0.01% | 0.0% |
| Q3 2022 | $425,000 | +5.5% | 22,287 | +13.8% | 0.01% | +20.0% |
| Q2 2022 | $403,000 | -33.6% | 19,579 | +3.8% | 0.01% | -28.6% |
| Q1 2022 | $607,000 | – | 18,864 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM ASSET MANAGEMENT LLC | 2,738,785 | $37,274,864 | 15.53% |
| MPM BioImpact LLC | 1,745,943 | $23,762,284 | 6.17% |
| Saturn V Capital Management LP | 480,653 | $6,541,687 | 4.89% |
| Boxer Capital, LLC | 2,154,058 | $29,317 | 1.44% |
| RA Capital Management | 4,417,259 | $60,118,895 | 1.36% |
| Octagon Capital Advisors LP | 596,000 | $8,111,560 | 1.17% |
| BVF INC/IL | 1,810,835 | $24,645,464 | 0.90% |
| AlphaCentric Advisors LLC | 63,000 | $857,430 | 0.59% |
| Integral Health Asset Management, LLC | 180,000 | $2,449,800 | 0.49% |
| 683 Capital Management, LLC | 480,000 | $6,532,800 | 0.49% |